Genomic and Proteomic Profiling of Lung Cancers: Lung Cancer Classification in the Age of Targeted Therapy
- 10 May 2005
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (14) , 3219-3226
- https://doi.org/10.1200/jco.2005.15.511
Abstract
Both proteomic and genomic methods offer promise for the classification of human lung carcinomas. This review summarizes the range of proteomic methods in development for lung cancer classification, and describes a number of recent analyses of messenger RNA expression in lung cancer. Multiple independent studies of mRNA expression profiles in lung adenocarcinoma have proven highly reproducible. Analyses of the relationship between expression profiles and tumor development and differentiation, the presence or absence of specific pathogenic mutations, patient prognosis and survival after surgical treatment, and specific histopathology all appear to be promising.Keywords
This publication has 62 references indexed in Scilit:
- An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysisNature Genetics, 2004
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- A combination of different mass spectroscopic techniques for the analysis of dynamic changes of histone modificationsProteomics, 2004
- Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarraysProteomics, 2003
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002
- A database of protein expression in lung cancerProteomics, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000